Imaging in stroke - An overview and recommendations from the German competence network stroke;Bildgebung beim schlaganfall - Eine übersicht und empfehlungen des kompetenznetzes schlaganfall

Aktuelle Neurologie

Volumn 36, Issue 7, 2009, Pages 354-367

  Thomalla, G ^a   Audebert, H J ^b   Berger, K ^c   Fiebach, J B ^d   Fiehler, J ^a   Kaps, M ^e   Neumann Haefelin, T ^f   Schellinger, P D ^g   Siebler, M ^h   Sobesky, J ^d   Villringer, A ^b   Witte, O W ⁱ   Rother J ^j  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Centrum für Schlaganfallforschung Berlin CSB   (Germany)

^e UNIVERSITY HOSPITAL GIESSEN   (Germany)

^f GOETHE UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h Fachbereich Neurologie   (Germany)

ⁱ FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^j KLINIKUM MINDEN   (Germany)

more..

Author keywords

Computed tomography; Maging; Magnetic resonance imaging; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICONVULSIVE AGENT; BAPINEUZUMAB; BARBITURIC ACID DERIVATIVE; BETA INTERFERON; BETA1A INTERFERON; BEVACIZUMAB; CLADRIBINE; CORTISONE; ETIRACETAM; FINGOLIMOD; HOMOTAURINE; LAMOTRIGINE; LENTIVIRUS VECTOR; METHYLPREDNISOLONE; NATALIZUMAB; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREDNISOLONE; PROSAVIN; RASAGILINE; RITUXIMAB; TARENFLURBIL; TISSUE PLASMINOGEN ACTIVATOR; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VARENICLINE;

ALZHEIMER DISEASE; ATAXIA; BRAIN DEPTH STIMULATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; EPILEPSY; EPILEPTIC STATE; FALLING; FIBRINOLYTIC THERAPY; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; FRAGILITY FRACTURE; FRONTOTEMPORAL DEMENTIA; GLIOBLASTOMA; GLIOMA; HUMAN; MONOTHERAPY; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROLOGY; PARANEOPLASTIC NEUROPATHY; PARKINSON DISEASE; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SPINOCEREBELLAR DEGENERATION; STROKE;

EID: 70349413280     PISSN: 03024350     EISSN: 14389428     Source Type: Journal    
DOI: 10.1055/s-0029-1220430     Document Type: Review

References (142)

1. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 2008; 25: 457-507
2. Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association / American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711
3. Thomalla G, Ringleb P, Kohrmann M et al. Patientenauswahl zur Thrombolyse mittels Perfusions- und Diffusions-MRT. [Patient selection for thrombolysis using perfusion and diffusion MRI: An overview·] Nervenarzt 2009; 80: 119-129
4. Hjort N, Butcher K, Davis SM et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005; 36: 388-397, Epub 2004 Dec 23
5. Hacke W, Furlan A for the DIAS-2 Investigators. Results from the phase III study of Desmoteplase in acute ischemi stroke trial 2 (DIAS 2). Cerebrovasc Dis 2007; 23: 54
6. Kohrmann M, Juttler E, Huttner HB et al. Acute Stroke Imaging for Thrombolytic Therapy - An Update. Cerebrovasc Dis 2007; 24: 161169 (Pubitemid 47295580)
7. Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol 2008; 7: 256-267
8. Parizel PM, Makkat S, Van Miert E et al. Intracranial hemorrhage: principles of CT and MRI interpretation. Eur Radiol 2001; 11: 17701783
9. Patel MR, Edelman RR, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke1996; 27: 2321-2324
10. Schellinger PD, Jansen O, Fiebach JB et al. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke 1999; 30: 765-768 (Pubitemid 29156365)
11. Fiebach JB, Schellinger PD, Gass A et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004; 35: 502-506, Epub 2004 Jan 22
12. Kidwell CS, Chalela JA, Saver JL et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004; 292: 18231830
13. Packard AS, Kase CS, Aly AS et al. "Computed tomography-negativ'' intracerebral hemorrhage: case report and implications for management. Arch Neurol 2003; 60: 1156-1159
14. Chalela JA, Kidwell CS, Nentwich LM et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007; 369: 293-298
15. Diener HC, Putzki NH. Leitlinien für Diagnostik und Therapie in der Neurologie. Kommission"Leitlinien" der Deutschen Gesellschaft fur Neurologie. ed 4., überarb. Aufl. Stuttgart, New York: Georg Thieme Verlag, 2008
16. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587
17. Clark WM, Albers GW, Madden KP et al. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thrombolytic therapy in acute ischemic stroke study investigators. Stroke 2000; 31: 811-816
18. Clark WM, Wissman S, Albers GW et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282: 2019-2026
19. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
20. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025
21. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebocontrolled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-1251
22. Schuier FJ, Hossmann KA. Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke 1980; 11: 593-601
23. Watanabe O, West CR, Bremer A. Experimental regional cerebral ischemia in the middle cerebral artery territory in primates. Part 2: Effects on brain water and electrolytes in the early phase of MCA stroke. Stroke 1977; 8: 71-76
24. Kucinski T, Vaterlein O, Glauche V et al. Correlation of apparent diffusion coefficient and computed tomography density in acute ischemic stroke. Stroke 2002; 33: 1786-1791
25. Kucinski T, Majumder A, Knab R et al. Cerebral perfusion impairment correlates with the decrease of CT density in acute ischaemic stroke. Neuroradiology 2004; 46: 716-722
26. Kummer R von, Bourquain H, Bastianello S et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 2001;219: 95-100
27. Kummer R von, Meyding-Lamade U, Forsting M et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 1994; 15: 9-15, discussion 16-18
28. Larrue V, Kummer RR von, Muller A et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001; 32: 438-441
29. Tanne D, Kasner SE, Demchuk AM et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002; 105: 1679-1685
30. Lyden P. Early major ischemic changes on computed tomography should not preclude use of tissue plasminogen activator. Stroke 2003; 34: 821-822
31. Kummer R von. Early major ischemic changes on computed tomography should preclude use of tissue plasminogen activator. Stroke 2003; 34: 820-821
32. Kummer R von, Allen KL, Holle R et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997; 205: 327-333
33. Patel SC, Levine SR, Tilley BC et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001; 286: 2830-2838
34. Saur D, Kucinski T, Grzyska U et al. Sensitivity and interrater agreement of CT and diffusion-weighted MR imaging in hyperacute stroke. AJNR Am J Neuroradiol 2003; 24: 878-885
35. Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment - systematic review. Radiology 2005; 235: 444-453
36. Kummer R von. Effect of training in reading CT scans on patient selection for ECASS II. Neurology 1998; 51: S50-52
37. Barber PA, Demchuk AM, Zhang J et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670-1674
38. Na DG, Kim EY, Ryoo JW et al. CT sign of brain swelling without concomitant parenchymal hypoattenuation: comparison with diffusion- and perfusion-weighted MR imaging. Radiology 2005; 235: 992-1948
39. Tomsick TA, Brott TG, Chambers AA et al. Hyperdense middle cerebral artery sign on CT: efficacy in detecting middle cerebral artery thrombosis. AJNR Am J Neuroradiol 1990; 11: 473-477
40. Barber PA, Demchuk AM, Hill MD et al. The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies. J Neurol Neurosurg Psychiatry 2004; 75: 1426-1430
41. Wolpert SM, Bruckmann H, Greenlee R et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993; 14: 3-13 (Pubitemid 23055914)
42. Muir KW, Buchan A, Kummer R von et al. Imaging of acute stroke. Lancet Neurol 2006; 5: 755-768
43. Rother J. CT and MRI in the diagnosis of acute stroke and their role in thrombolysis. Thromb Res 2001; 103: S125-133
44. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 2002; 15: 435-455
45. Sotak CH. The role of diffusion tensor imaging in the evaluation of ischemic brain injury - a review. NMR Biomed 2002; 15: 561-569
46. Hoehn-Berlage M, Norris DG, Kohno K et al. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab 1995; 15: 1002-1011
47. Moseley ME, Kucharczyk J, Mintorovitch J et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 1990; 11: 423-429
48. Rother J, de Crespigny AJ, D'Arceuil H et al. Recovery of apparent diffusion coefficient after ischemia-induced spreading depression relates to cerebral perfusion gradient. Stroke 1996; 27: 980-986, discussion 986-987
49. Fiebach JB, Schellinger PD, Jansen O et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002; 33: 2206-2210
50. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging 2005; 22: 710-717 (Pubitemid 41741235)
51. Rosen BR, Belliveau JW, Vevea JM et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14: 249-265
52. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981; 12: 723-725
53. Baron JC, Rougemont D, Soussaline F et al. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab 1984; 4: 140-149
54. Heiss WD. Flow thresholds of functional and morphological damage of brain tissue. Stroke 1983; 14: 329-331
55. Baron JC, Kummer R von, del Zoppo GJ. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke 1995; 26: 2219-2221
56. Schlaug G, Benfield A, Baird AE et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999; 53: 1528-1537
57. Warach S. Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI. Ann Neurol 2002; 51: 11-13
58. Fiehler J, Foth M, Kucinski T et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002; 33: 79-86
59. Fiehler J, Knudsen K, Kucinski T et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 2004; 35: 514519
60. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003; 34: 2729-2735, Epub 2003 Oct 23
61. Heiss WD, Sobesky J, Hesselmann V. Identifying thresholds for penumbra and irreversible tissue damage. Stroke 2004; 35: 2671-2674
62. Sobesky J, Zaro Weber O, Lehnhardt FG et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005; 36: 980-985
63. Sobesky J, Zaro Weber O, Lehnhardt FG et al. Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004; 35: 2843-2847
64. Zaro-Weber O, Moeller-Hartmann W, Heiss WD et al. The Performance of MRI-Based Cerebral Blood Flow Measurements in Acute and Subacute Stroke Compared With 15O-Water Positron Emission Tomography. Identification of Penumbral Flow. Stroke 2009; 40: 2413-2421
65. Kakuda W, Lansberg MG, Thijs VN et al. Optimal definition for PWI / DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 2008; 28: 887-891
66. Olivot JM, Mlynash M, Thijs VN et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009; 40: 469-475
67. Wintermark M, Albers GW, Alexandrov AV et al. Acute stroke imaging research roadmap. Stroke 2008; 39: 1621-1628
68. Jansen O, Schellinger P, Fiebach J et al. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet 1999; 353: 2036-2037
69. Parsons MW, Barber PA, Chalk J et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002; 51: 28-37
70. Schellinger PD, Jansen O, Fiebach JB et al. Monitoring intravenous re-combinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000; 31: 1318-1328
71. Nighoghossian N, Hermier M, Adeleine P et al. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. Stroke 2003; 34: 458-463
72. Kohrmann M, Juttler E, Fiebach JB et al. MRI versus CT-based throm-bolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006; 5: 661-667
73. Ribo M, Molina CA, Rovira A et al. Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler / MRI Selection Protocol. Stroke 2005; 36: 602-606
74. Schellinger PD, Thomalla G, Fiehler J et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007; 38: 2640-2645
75. Thomalla G, Schwark C, Sobesky J et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 2006; 37: 852-858
76. Caplan LR. Stroke thrombolysis: slow progress. Circulation 2006;114: 187-190
77. Fisher M. Is penumbral imaging useful for extending the treatment window for intravenous tissue plasminogen activator? Ann Neurol 2006; 60: 499-501
78. Sacco RL, ChongJY, Prabhakaran S et al. Experimental treatments for acute ischaemic stroke. Lancet 2007; 369: 331-341
79. Weimar C, Diener HC. What's new in stroke prevention and treatment. Expert Rev Neurother 2006; 6: 185-193
80. Albers GW, Thijs VN, Wechsler L et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508-517
81. Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7: 299-309
82. Furlan AJ, Eyding D, Albers GW et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006; 37: 1227-1231
83. Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73, Epub 2004 Nov 29
84. Hacke W, Furlan AJ, Al-Rawi Y et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8: 141-150
85. Singer OC, Humpich MC, Fiehler J et al. Risk for symptomatic intra-cerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 2008; 63: 52-60
86. Neumann-Haefelin T, Hoelig S, Berkefeld J et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 2006; 37: 2463-2466
87. Palumbo V, Boulanger JM, Hill MD et al. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007; 68: 1020-1024
88. Fiehler J, Albers GW, Boulanger JM et al. Bleeding risk analysis in stroke imaging before thrombolysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 2007; 38: 2738-2744
89. Schellinger PD, Richter G, Kohrmann M et al. Noninvasive angiography (magnetic resonance and computed tomography) in the diagnosis of ischemic cerebrovascular disease. Techniques and clinical applications. Cerebrovasc Dis 2007; 24 (Suppl. 1): 16-23
90. Tomandl BF, Klotz E, Handschu R et al. Comprehensive imaging ofischemic stroke with multisection CT. Radiographics 2003; 23: 565-592
91. Schramm P, Schellinger PD, Fiebach JB et al. Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke 2002; 33: 2426-2432
92. Koenig M, Klotz E, Luka B et al. Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke. Radiology 1998; 209: 85-93
93. Nagata K, Asano T. Functional image of dynamic computed tomography for the evaluation of cerebral hemodynamics. Stroke 1990; 21: 882-889
94. Koenig M, Kraus M, Theek C et al. Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT. Stroke 2001; 32: 431-437
95. Wintermark M, Flanders AE, Velthuis B et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006; 37: 979-985
96. Eastwood JD, Lev MH, Wintermark M et al. Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. AJNR Am J Neuroradiol 2003; 24: 1869-1875
97. Wintermark M, Reichhart M, Cuisenaire O et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002; 33: 2025-2031
98. Wintermark M, Meuli R Browaeys P et al. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology 2007; 68: 694-697
99. Kang DW, Chalela JA, Dunn W et al. MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke 2005; 36: 1939-1943
100. Earnshaw SR, Jackson D, Farkouh R et al. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis. Stroke 2009; 40: 1710-1720
101. Gesellschaft fur Qualitätssicherung Hessen. Auswertung der Statistik fur das Jahr 2006. http://www.gqhnet.de/Projekte/Akut/Auswertun gen/2005-schlaganfall-akut-pdf ( access 27.6.2009)
102. Baumgartner RW, Mattle HP, Schroth G. Assessment of > 50% and > 50 % intracranial stenoses by transcranial color-coded duplex sonography. Stroke 1999; 30: 87-92
103. Gerriets T, Goertler M, Stolz E et al. Feasibility and validity of transcranial duplex sonography in patients with acute stroke. J Neurol Neurosurg Psychiatry 2002; 73: 17-20
104. Jahromi AS, Cina CS, Liu Y et al. Sensitivity and specificity of color duplex ultrasound measurement in the estimation of internal carotid 367 artery stenosis: a systematic review and meta-analysis. J Vasc Surg 2005; 41: 962-972
105. Seidel G, Kaps M, Gerriets T. Potential and limitations of transcranial color-coded sonography in stroke patients. Stroke 1995; 26: 2061-2066
106. Alexandrov AV, Demchuk AM, Felberg RA et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke 2000; 31: 610-614
107. Allendoerfer J, Goertler M, Reutern GM von. Prognostic relevance of ultra-early doppler sonography in acute ischaemic stroke: a prospective multicentre study. Lancet Neurol 2006; 5: 835-840
108. Kaps M, Stolz E, Allendoerfer J. Prognostic value of transcranial sonography in acute stroke patients. Eur Neurol 2008; 59(Suppl.1): 9-16
109. Stolz E, Cioli F, Allendoerfer J et al. Can early neurosonology predict outcome in acute stroke? a metaanalysis of prognostic clinical effect sizes related to the vascular status. Stroke 2008; 39: 3255-3261
110. Ribo M, Alvarez-Sabin J, Montaner J et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006; 37: 1000-1004
111. Cupini LM, Diomedi M, Placidi F et al. Cerebrovascular reactivity and subcortical infarctions. Arch Neurol 2001; 58: 577-581
112. Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001; 124: 457-467
113. Markus HS, Droste DW, Kaps M et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111: 2233-2240
114. EydingJ, Krogias C, Schollhammer M et al. Contrast-enhanced ultrasonic parametric perfusion imaging detects dysfunctional tissue at risk in acute MCA stroke. J Cereb Blood Flow Metab 2006; 26: 576-582
115. Wiesmann M, Meyer K, Albers T et al. Parametric perfusion imaging with contrast-enhanced ultrasound in acute ischemic stroke. Stroke 2004; 35: 508-513 (Pubitemid 38174439)
116. Eckert B, Koch C, Thomalla G et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/ stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 2005; 36: 1160-1165, Epub 2005 May 12
117. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006; 37: 922-928
118. Nagel S, Schellinger PD, Hartmann M et al. Therapy of acute basilar artery occlusion: intraarterial thrombolysis alone vs bridging therapy. Stroke 2009; 40: 140-146
119. Arnold M, Schroth G, Nedeltchev K et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002; 33: 1828-1833
120. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999; 9: 193-201
121. Heiss WD, Kracht LW, Thiel A et al. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 2001; 124: 20-29
122. Takasawa M, Jones PS, Guadagno JV et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 2008; 39: 870-877
123. Heiss WD, Podreka I. Role of PET and SPECT in the assessment of ischemic cerebrovascular disease. Cerebrovasc Brain Metab Rev 1993; 5: 235-263
124. Chavez JC, Zaleska MM, Wang X et al. Multimodal magnetic resonance imaging for assessing evolution of ischemic penumbra: a key translational medicine strategy to manage the risk of developing novel therapies for acute ischemic stroke. J Cereb Blood Flow Metab 2009; 29: 217-219
125. Wu O, Christensen S, Hjort N et al. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. Brain 2006; 129: 2384-2393
126. Serena J, Davalos A, Segura Tet al. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis 2003; 16: 128-133
127. Thomalla G, Rossbach P, Rosenkranz M et al. Negative FLAIR imaging identifies acute ischemic stroke > 3 hours. Ann Neurol in press
128. Cho AH, Sohn SI, Han MK et al. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008; 25: 572-579
129. Hellier KD, Hampton JL, Guadagno JV et al. Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry 2006; 77: 417-419
130. IosifC, Oppenheim C, Trystram D et al. MR imaging-based decision in thrombolytic therapy for stroke on awakening: report of 2 cases. AJNR Am J Neuroradiol 2008; 29: 1314-1316
131. Munoz Maniega S, Cvoro V, Chappell FM et al. Changes in NAA and lactate following ischemic stroke: a serial MR spectroscopic imaging study. Neurology 2008; 71: 1993-1999
132. Geisler BS, Brandhoff F, Fiehler J et al. Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 2006; 37: 1778-1784
133. Siemonsen S, Fitting T, Thomalla G et al. T2' imaging predicts infarct growth beyond the acute diffusion-weighted imaging lesion in acute stroke. Radiology 2008; 248: 979-986
134. Lee JI, Wittsack HJ, Christaras A et al. Normalization of brain tissue lactate after hyperbaric oxygen therapy in a progressive stroke patient. Cerebrovasc Dis 2008; 26: 447-448
135. Stengel A, Neumann-Haefelin T, Singer OC et al. Multiple spin-echo spectroscopic imaging for rapid quantitative assessment of N-acetylaspartate and lactate in acute stroke. Magn Reson Med 2004; 52: 228-238
136. Hampson M, Peterson BS, Skudlarski P et al. Detection of functional connectivity using temporal correlations in MR images. Hum Brain Mapp 2002; 15: 247-262
137. Kunimatsu A, Aoki S, Masutani Y et al. Three-dimensional white matter tractography by diffusion tensor imaging in ischaemic stroke involving the corticospinal tract. Neuroradiology 2003; 45: 532-535
138. Lie C, Hirsch JG, Rossmanith C et al. Clinicotopographical correlation of corticospinal tract stroke: a color-coded diffusion tensor imaging study. Stroke 2004; 35: 86-92
139. Thomalla G, Glauche V, Koch MA et al. Diffusion tensor imaging detects early Wallerian degeneration of the pyramidal tract after ischemic stroke. Neuroimage 2004; 22: 1767-1774
140. Alexandrov AV, Molina CA, Grotta JC et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178
141. Molina CA, Ribo M, Rubiera M et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006; 37: 425-429
142. Daffertshofer M, Gass A, Ringleb P et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke 2005; 36: 1441-1446